PQA News

Latest Articles

• News Article
  January 23, 2026

  PQA Resource Guide Details Strategic Approaches to SDOH Intervention Success

  PQA releases the SDOH Resource Companion Guide, highlighting successful partnerships and strategies to address health-related social needs effectively.
• PQA Blogs
  
  January 16, 2026

  Five for Friday January 16: Celebrating Success in Advancing Medication Use Quality

  The PQA Social Determinants of Health (SDOH) Resource Guide Companion provides insights on key characteristics of effective partnerships among pharmacies, other health care organizations and community organizations to address SDOH barriers affecting medication access, use and outcomes.
• News Article
  January 15, 2026

  2026 Health Care Outlook: Micah Cost, PQA

• PQA Blogs
  
  January 13, 2026

  PQA Appoints Individuals to Serve on 2026 Panels

  PQA has appointed individuals from member organizations to serve on the 2026 PQA Measure Update Panel (MUP) and Quality Metrics Expert Panel (QMEP). The panelists self-nominated and were selected by PQA staff to create a balanced group that represents PQA’s membership and includes relevant expertise. Measure Update Panel (MUP) The MUP is a select group […]
• PQA Blogs
  
  January 8, 2026

  PQA Prioritizes Health Plan Measure Concepts for Future Development 

  Early in the measure life cycle, PQA solicits multi-stakeholder input to evaluate and prioritize health plan measure concepts for future development. To support measure conceptualization in 2025, PQA convened a Measure Concept Advisory Group (MCAG) and conducted a public comment period to inform future measure development, with a particular focus on addressing meaningful gaps in medication use quality while ensuring measure concepts are evidence-based and […]
• PQA Blogs
  
  December 31, 2025

  PQA Quality Leadership Program Expanded in 2025

  The PQA Quality Leadership Program expanded in 2025 to increase opportunities for all professionals at PQA member organizations and students to hone their skills in medication use quality and gain valuable knowledge about PQA’s measure development process and the measure life cycle. Eleven individuals were selected to shadow the Quality Metrics Expert Panel or the Measure Update […]
• Press Release
  
  December 29, 2025

  PQA Releases Social Determinants of Health Resource Guide Companion

  Companion Provides Insights on Partnerships for Improving Medication Use Quality Alexandria, Va. (December 29, 2025) – The Pharmacy Quality Alliance (PQA) has released a PQA Social Determinants of Health (SDOH) Resource Guide Companion, which provides insights on key characteristics of effective partnerships among pharmacies, other health care organizations and community organizations to address SDOH barriers affecting medication […]
• PQA Blogs
  
  December 19, 2025

  Five for Friday December 19: Celebrating Success in Advancing Medication Use Quality

  The PQA Board of Directors has adopted the goals and objectives of PQA's next strategic plan, Blueprint PQA 2030, which will guide our work from 2026 through 2030. This follows our highly successful Leadership Summit, where PQA members provided insights and guidance on the strategies and tactics that will be important for our success in the coming years.
• PQA Blogs
  
  December 5, 2025

  Five for Friday December 5: Celebrating Success in Advancing Medication Use Quality

  A research partnership between PQA, Merck, and the University of Mississippi focused on three PQA adherence measures to continue to monitor their impact. The project examined Medicare Advantage enrollees who were taking either diabetes, renin-angiotensin system antagonist, or statin medications. The study found that higher proportion of days covered (PDC) in one year was associated […]
• PQA Blogs
  
  November 25, 2025

  Better Adherence Lowers Payer Medical Costs

  A research partnership between PQA, Merck, and the University of Mississippi focused on three PQA adherence measures to continue to monitor their impact.   Using administrative claims data from Optum’s de-identified Clinformatics® Data Mart Database, the project examined Medicare Advantage enrollees who were taking either diabetes, renin-angiotensin system antagonist (RASA), or statin medications.  Findings suggest the average patient-level adherence rate was between 84%-89% across the three medication classes using a modified […]